Engineering liver tissue from induced pluripotent stem cells: a first step in generating new organs for transplantation?
Engineering liver tissue from induced pluripotent stem cells: a first step in generating new organs for transplantation?
复制标题
DOI:
10.1002/hep.26737
复制
发表时间:
2013-12
期刊:
影响因子:
13.5
通讯作者:
Duncan, Stephen A.
中科院分区:
文献类型:
--
作者:
Fox, Ira J.;Duncan, Stephen A.
A critical shortage of donor organs for treating end-stage organ failure highlights the urgent need for generating organs from human induced pluripotent stem cells (iPSCs). Despite many reports describing functional cell differentiation, no studies have succeeded in generating a three-dimensional vascularized organ such as liver. Here we show the generation of vascularized and functional human liver from human iPSCs by transplantation of liver buds created in vitro (iPSC-LBs). Specified hepatic cells (immature endodermal cells destined to track the hepatic cell fate) self-organized into three-dimensional iPSC-LBs by recapitulating organogenetic interactions between endothelial and mesenchymal cells. Immunostaining and gene-expression analyses revealed a resemblance between in vitro grown iPSC-LBs and in vivo liver buds. Human vasculatures in iPSC-LB transplants became functional by connecting to the host vessels within 48 hours. The formation of functional vasculatures stimulated the maturation of iPSC-LBs into tissue resembling the adult liver. Highly metabolic iPSC-derived tissue performed liver-specific functions such as protein production and human-specific drug metabolism without recipient liver replacement. Furthermore, mesenteric transplantation of iPSC-LBs rescued the drug-induced lethal liver failure model. To our knowledge, this is the first report demonstrating the generation of a functional human organ from pluripotent stem cells. Although efforts must ensue to translate these techniques to treatments for patients, this proof-of concept demonstration of organ-bud transplantation provides a promising new approach to study regenerative medicine.
登录
查看更多内容
影响因子:
46.9
作者:
通讯作者:
--
DOI:
10.1073/pnas.1101791108
发表时间:
2011-07-19
影响因子:
11.1
作者:
Chen, Alice A.;Thomas, David K.;Bhatia, Sangeeta N.
通讯作者:
Bhatia, Sangeeta N.
DOI:
10.1073/pnas.0908381106
发表时间:
2009-09-29
影响因子:
11.1
作者:
Stevens, K. R.;Kreutziger, K. L.;Murry, C. E.
通讯作者:
Murry, C. E.
影响因子:
46.9
作者:
Kroon, Evert;Martinson, Laura A.;Baetge, Emmanuel E.
通讯作者:
Baetge, Emmanuel E.
影响因子:
11.8
作者:
Nolan, Daniel J.;Ginsberg, Michael;Israely, Edo;Palikuqi, Brisa;Poulos, Michael G.;James, Daylon;Ding, Bi-Sen;Schachterle, William;Liu, Ying;Rosenwaks, Zev;Butler, Jason M.;Xiang, Jenny;Rafii, Arash;Shido, Koji;Rabbany, Sina Y.;Elemento, Olivier;Rafii, Shahin
通讯作者:
Rafii, Shahin